These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26772815)

  • 1. CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism.
    Maayah ZH; Althurwi HN; Abdelhamid G; Lesyk G; Jurasz P; El-Kadi AO
    Pharmacol Res; 2016 Mar; 105():28-43. PubMed ID: 26772815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.
    Maayah ZH; Althurwi HN; El-Sherbeni AA; Abdelhamid G; Siraki AG; El-Kadi AO
    Mol Cell Biochem; 2017 May; 429(1-2):151-165. PubMed ID: 28251434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.
    Shoieb SM; El-Kadi AOS
    Mol Cell Biochem; 2020 Aug; 471(1-2):165-176. PubMed ID: 32533462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Mid-chain HETEs Protects Against Angiotensin II-induced Cardiac Hypertrophy.
    Elkhatali S; Maayah ZH; El-Sherbeni AA; Elshenawy OH; Abdelhamid G; Shoieb SM; El-Kadi AOS
    J Cardiovasc Pharmacol; 2017 Jul; 70(1):16-24. PubMed ID: 28437282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
    Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
    Toxicol Appl Pharmacol; 2010 Jan; 242(1):38-46. PubMed ID: 19796650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-κB-dependent mechanism.
    Maayah ZH; El-Kadi AO
    Arch Toxicol; 2016 Feb; 90(2):359-73. PubMed ID: 25600587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.
    Maayah ZH; El-Kadi AO
    Arch Toxicol; 2016 Jan; 90(1):119-36. PubMed ID: 26525395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
    Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
    Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver.
    Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
    Drug Metab Dispos; 2011 Aug; 39(8):1440-50. PubMed ID: 21571947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.
    Alsaad AM; Zordoky BN; El-Sherbeni AA; El-Kadi AO
    Drug Metab Dispos; 2012 Nov; 40(11):2126-35. PubMed ID: 22867862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity.
    Gu J; Hu W; Song ZP; Chen YG; Zhang DD; Wang CQ
    Int Immunopharmacol; 2016 Mar; 32():1-7. PubMed ID: 26774212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.
    Grant MK; Seelig DM; Sharkey LC; Zordoky BN
    Biol Sex Differ; 2017; 8():1. PubMed ID: 28078076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 19-(
    Shoieb SM; El-Sherbeni AA; El-Kadi AOS
    Drug Metab Dispos; 2019 Feb; 47(2):67-70. PubMed ID: 30420405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways.
    El-Said NT; Mohamed EA; Taha RA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):647-658. PubMed ID: 30734091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
    Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
    Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats.
    Haybar H; Goudarzi M; Mehrzadi S; Aminzadeh A; Khodayar MJ; Kalantar M; Fatemi I
    Biomed Pharmacother; 2019 Jan; 109():530-535. PubMed ID: 30551518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy.
    Alammari AH; Shoieb SM; Maayah ZH; El-Kadi AOS
    J Pharm Sci; 2020 Jul; 109(7):2321-2335. PubMed ID: 32240690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
    Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
    Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
    Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
    Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction-Induced Cardiac Hypertrophy in Rats.
    Shoieb SM; Alammari AH; Levasseur J; Silver H; Dyck JRB; El-Kadi AOS
    J Cardiovasc Pharmacol; 2022 Jun; 79(6):833-845. PubMed ID: 35266922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.